Comparison of the efficacy and safety of bupropion versus aripiprazole augmentation in adults with treatment-resistant depression: a nationwide cohort study in South Korea
Abstract Background Treatment-resistant depression (TRD) affects 10–30% of patients with major depressive disorder, leading to increased comorbidities, higher mortality, and significant economic and social burdens. This study aimed to compare the efficacy and safety of bupropion and aripiprazole a...
Saved in:
| Main Authors: | Dong Yun Lee, Rae Woong Park, Soo Min Jeon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-01-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933824018157/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of outcome of major depressive disorder treatment as per evidence based treatment protocol devised by department of psychiatry
by: R S Rawat, et al.
Published: (2015-07-01) -
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
by: Sugawara H, et al.
Published: (2016-05-01) -
Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01) -
Can dextromethorphan-bupropion reduce mental pain in depressed individuals? A hypothesis-generating overview perspective
by: Maurizio Pompili, et al.
Published: (2025-03-01) -
Depression, antidepressant use, and breast cancer incidence in the Sister Study cohort
by: Mary V. Díaz-Santana, et al.
Published: (2025-05-01)